podophyllotoxin has been researched along with Uterine Cervical Neoplasms in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (53.57) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Andrei, G; Birkus, G; Christensen, ND; Doerrfler, E; Lee, WA; Ray, AS; Reiser, H; Shibata, R; Snoeck, R; Wang, J; Wolfgang, GH; Wu, S | 1 |
| Fu, Y; Shen, J; Wan, S; Wang, H; Wang, X; Yang, J; Zhang, Z; Zhao, J; Zhou, T | 1 |
| Lopaschuk, CC | 1 |
| Bechtel, MA; Trout, W | 1 |
| Kim, CG; Lee, YH; Lim, Y; Shin, SY; Yong, Y | 1 |
| Chen, L; Huang, Z; Shi, P; Wang, B; Zhen, H; Zhou, L | 1 |
| Li, GF; Shi, YJ; Sun, LD; Yang, XX; Zeng, K; Zhang, M; Zhu, XL | 1 |
| Blessing, JA; Homesley, HD; Slayton, RE | 1 |
| Buchardt, O; Ebbesen, P; Hansen, HF; Jensen, RB; Nielsen, PE; Nørskov-Lauritsen, N; Willumsen, AM | 1 |
| Bistoletti, P; Löwhagen, GB; Persson, G; Rylander, E; Von Krogh, G | 1 |
| Rylander, E; Strand, A; Wilander, E; Zehbe, I | 1 |
| Bundy, BN; Given, FT; Muss, HB; Stehman, FB | 1 |
| Bertelsen, K; Cold, S; Panduro, J; Pfeiffer, P; Rose, C; Sandberg, E | 1 |
| Bundy, BN; Muss, HB; Yazigi, R; Yordan, E | 1 |
| Brachetti, A; Leonhardt, A; Limburg, H; Osswald, H; Schmähl, D | 1 |
| KAMINETZKY, HA; MCGREW, EA | 2 |
| STAMM, O | 1 |
| KLINE, TS; LEVENTHAL, ML; SAPHIR, O | 1 |
| Armborst, V | 1 |
| Limburg, H | 1 |
| Krishnamurthi, S; Nair, MK; Shanta, V | 1 |
| Harms, J; Heckmann, U; Tranckjer, AS | 1 |
| Paeschke, KD | 2 |
| Kaminetzky, HA; Swerdlow, M | 1 |
| Garret, M | 1 |
2 review(s) available for podophyllotoxin and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
New approach to managing genital warts.
Topics: Aminoquinolines; Clinical Protocols; Condylomata Acuminata; Female; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Uterine Cervical Neoplasms | 2013 |
Sexually transmitted diseases.
Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine | 2015 |
2 trial(s) available for podophyllotoxin and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Studies of chemical sensitization in the radiotherapy of oral and cervical carcinomas.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cobalt Isotopes; Female; Follow-Up Studies; Humans; Mouth Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Radiotherapy Dosage; Uterine Cervical Neoplasms; Vaginal Smears; Vitamin K | 1967 |
[Combination of radiotherapy of carcinoma of the cervix with cobalt-60-radium-gamma-irradiation and the use of the cytostatic drug SP-I/SP-G].
Topics: Antineoplastic Agents; Cobalt Isotopes; Female; Humans; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Radioisotope Teletherapy; Radium; Uterine Cervical Neoplasms | 1965 |
24 other study(ies) available for podophyllotoxin and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Female; Guanine; Humans; Male; Nucleic Acid Synthesis Inhibitors; Phenylalanine; Prodrugs; Rabbits; Uterine Cervical Neoplasms | 2009 |
PICT1 is critical for regulating the Rps27a-Mdm2-p53 pathway by microtubule polymerization inhibitor against cervical cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Podophyllotoxin; Proto-Oncogene Proteins c-mdm2; Ribosomal Proteins; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitins; Uterine Cervical Neoplasms | 2021 |
Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in HeLa cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Ataxia Telangiectasia Mutated Proteins; bcl-2-Associated X Protein; Caspase 3; Caspase 7; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Proliferation; Cell Survival; Checkpoint Kinase 2; DNA Fragmentation; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme Activation; Female; G2 Phase; HeLa Cells; Humans; Podophyllotoxin; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Time Factors; Tubulin Modulators; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2010 |
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts | 2012 |
Proteomic changes induced by podophyllotoxin in human cervical carcinoma HeLa cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Communication; Female; HeLa Cells; Humans; Neoplasm Proteins; Podophyllotoxin; Proteomics; Signal Transduction; Uterine Cervical Neoplasms | 2013 |
[Effects of podophyllotoxin solid lipid nanoparticles on proliferation and apoptosis of cervical carcinoma cells].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Delayed-Action Preparations; Drug Carriers; Female; HeLa Cells; Humans; Liposomes; Nanoparticles; Podophyllotoxin; Uterine Cervical Neoplasms | 2008 |
Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Podophyllotoxin; Uterine Cervical Neoplasms | 1984 |
New compounds related to podophyllotoxin and congeners: synthesis, structure elucidation and biological testing.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line; Cell Survival; Colony-Forming Units Assay; Cytomegalovirus; Female; Herpesvirus 2, Human; HIV; Humans; Mice; Podophyllotoxin; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1993 |
[Genital papillomavirus infection. A diagnostic and therapeutic dilemma].
Topics: Adult; Condylomata Acuminata; Diagnosis, Differential; Female; Fluorouracil; Humans; Male; Papillomaviridae; Penile Neoplasms; Podophyllotoxin; Uterine Cervical Neoplasms | 1993 |
High risk HPV persists after treatment of genital papillomavirus infection but not after treatment of cervical intraepithelial neoplasia.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; DNA Probes; DNA, Viral; Female; Humans; Middle Aged; Papillomaviridae; Papillomavirus Infections; Podophyllotoxin; Polymerase Chain Reaction; Risk; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1997 |
Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Podophyllotoxin; Prognosis; Teniposide; Uterine Cervical Neoplasms | 1990 |
Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
Topics: Adult; Aged; Carcinoma; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Survival; Teniposide; Uterine Cervical Neoplasms | 1990 |
Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Middle Aged; Podophyllotoxin; Teniposide; Uterine Cervical Neoplasms | 1987 |
[Clinical experiences with a combination therapy of metastasising genital and mammary carcinomas (author's transl)].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Cyclophosphamide; Cytidine; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Podophyllotoxin; Postoperative Care; Prognosis; Remission, Spontaneous; Thymidine; Uterine Cervical Neoplasms; Vinblastine | 1974 |
The genesis of experimental cervical epithelial dysplasia.
Topics: Female; Humans; Podophyllum; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1961 |
[ON CANCER THERAPY WITH PODOPHYLLIN DERIVATIVES. PRELIMINARY EXPERIENCES IN THE CYTOSTATIC TREATMENT OF MALIGNANT GENITAL TUMORS WITH SP-I AND SP-G SANDOZ].
Topics: Antineoplastic Agents; Choriocarcinoma; Cytostatic Agents; Female; Humans; Podophyllin; Podophyllum; Uterine Cervical Neoplasms; Uterine Neoplasms; Vaginal Neoplasms | 1964 |
Podophyllin-induced dysplasia of the cervix uteri; its histologic resemblance to carcinoma in situ.
Topics: Carcinoma in Situ; Female; Humans; Hyperplasia; Podophyllin; Podophyllum; Uterine Cervical Neoplasms | 1959 |
Podophyllin and mouse cervix. Effect of long-term application.
Topics: Animals; Cervix Uteri; Female; Humans; Mice; Neoplasms, Experimental; Podophyllin; Podophyllum; Uterine Cervical Neoplasms | 1962 |
[Possibilities of drug therapy of gynecologic malignancies].
Topics: Antineoplastic Agents; Cyclophosphamide; Female; Genital Neoplasms, Female; Humans; Isoenzymes; L-Lactate Dehydrogenase; Ovarian Neoplasms; Perchlorates; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Tryptophan; Uterine Cervical Neoplasms; Uterine Neoplasms | 1967 |
[Cytostatic treatment of genital carcinoma].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carcinoma, Papillary; Cyclophosphamide; Female; Genital Neoplasms, Female; Germany, West; Humans; Methotrexate; Ovarian Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Thiotepa; Triaziquone; Uterine Cervical Neoplasms; Uterine Neoplasms; Vinblastine | 1969 |
[Resistance formation in the cytostatic treatment of carcinomas].
Topics: Adenocarcinoma; Autoradiography; Carcinoma, Squamous Cell; Cystadenoma; Female; Genital Neoplasms, Female; Granulosa Cell Tumor; Humans; Ovarian Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Tritium; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 1969 |
[Problems in the chemotherapy of cervical carcinoma in the experience of the Göttingen University Gynecologic Clinic].
Topics: Antineoplastic Agents; Female; Humans; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Uterine Cervical Neoplasms | 1970 |
Podophyllin and the mouse cervix: assessment of carcinogenic potential.
Topics: Animals; Carcinogens; Female; Mice; Plants, Medicinal; Plants, Toxic; Podophyllum; Uterine Cervical Neoplasms | 1965 |
Relationship of podophyllin to carcinogenesis. A comparison of cytologic and histologic changes induced by podophyllin in the mouse cervix with those induced by 3,4 benzpyrene.
Topics: Animals; Antineoplastic Agents; Benzopyrenes; Carcinoma, Squamous Cell; Cervix Uteri; Female; Mice; Neoplasms, Experimental; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Uterine Cervical Neoplasms | 1966 |